SCHEMBL25683374

SCHEMBL25683374

CCCc1ccc2c(c1)c1c3oc4ccccc4c3ccc1n2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PDE10A Q9Y233 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ RORA P35398 2/20 0.36
▸ RORC P51449 2/20 0.36
▸ RORB Q92753 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HPGD P15428 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ ASAH1 Q13510 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ PGR P06401 1/20 0.33
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25996887 0.94 CYP1A2 (0.43) CYP1A2CYP2D6CYP2C19PDE10ASMN1; SMN2
SCHEMBL25683407 0.94 HPGD (0.40) CYP1A2CYP2D6CYP2C19PDE10ASMN1; SMN2
SCHEMBL25682837 0.91 CYP1A2 (0.39) CYP1A2CYP2D6CYP2C19PDE10ARAB9A
SCHEMBL25682860 0.90 ALDH1A1 (0.39) RAB9ARORARORCRORBHPGD
SCHEMBL19652580 0.86 KDM4E (0.40) CYP1A2CYP2D6CYP2C19PDE10ASMN1; SMN2
SCHEMBL25683028 0.85 CYP1A2 (0.40) CYP1A2CYP2D6CYP2C19PDE10ASMN1; SMN2
SCHEMBL25683121 0.85 CYP1A2 (0.45) CYP1A2CYP2D6CYP2C19PDE10ASMN1; SMN2
SCHEMBL25681998 0.84 KDM4E (0.40) CYP1A2CYP2D6CYP2C19SMN1; SMN2RAB9A
SCHEMBL13183691 0.82 GPR3 (0.47) CYP1A2CYP2D6CYP2C19HPGDKDM4E
SCHEMBL25678300 0.81 GPR3 (0.42) CYP2C19HPGDKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 CYP1A2 267/4885CYP2D6 1226/4885CYP2C19 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback